Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Investigation of breast cancer cell dormancy
EF 2018-19
Résumé
The majority of cancer-related deaths are caused by the spread of cancer cells to secondary sites in the body. These cells are difficult to kill using current cancer therapies due to their ability to stop dividing, allowing them to hide from chemotherapy. Months or years later, dormant cells may start growing again and cause cancer to return; therefore, dormancy is an important area of study. DREAM (DP, RB-family, E2F4/5, and MuvB) is a complex of proteins known to induce dormancy and allow ovarian cancer cells to survive as they spread. My proposed work aims to determine if DREAM behaves similarly in breast cancer and if it could be used as a drug target to reduce breast cancer spread. I have already identified conditions that stop breast cancer cells from growing and used gene-editing technology to create cells that no longer form DREAM, which will allow me to identify processes normally controlled by this complex in breast cancer. I will also observe how these cells spread in mice to investigate whether DREAM loss improves cancer prognosis. Overall, this project may identify mechanisms that contribute to breast cancer relapse and lead to development of new therapeutic tools to prevent cancer spread and reduce mortality rates.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
406369
Name
DeWeerd Megan
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigation of breast cancer cell dormancy
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Breast Cancer; Crispr; Dormancy; Dream; Metastasis; Protein Complex; Therapy; Xenograft
Abstract
The majority of cancer-related deaths are caused by the spread of cancer cells to secondary sites in the body. These cells are difficult to kill using current cancer therapies due to their ability to stop dividing, allowing them to hide from chemotherapy. Months or years later, dormant cells may start growing again and cause cancer to return; therefore, dormancy is an important area of study. DREAM (DP, RB-family, E2F4/5, and MuvB) is a complex of proteins known to induce dormancy and allow ovarian cancer cells to survive as they spread. My proposed work aims to determine if DREAM behaves similarly in breast cancer and if it could be used as a drug target to reduce breast cancer spread. I have already identified conditions that stop breast cancer cells from growing and used gene-editing technology to create cells that no longer form DREAM, which will allow me to identify processes normally controlled by this complex in breast cancer. I will also observe how these cells spread in mice to investigate whether DREAM loss improves cancer prognosis. Overall, this project may identify mechanisms that contribute to breast cancer relapse and lead to development of new therapeutic tools to prevent cancer spread and reduce mortality rates.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
DeWeerd, Megan
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~